Page last updated: 2024-08-23

detomidine and Weight Gain

detomidine has been researched along with Weight Gain in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huupponen, R; Koulu, M; Pesonen, U; Raasmaja, A; Rouru, J; Savola, JM; Savontaus, E; Virtanen, R	1

Other Studies

1 other study(ies) available for detomidine and Weight Gain

Article	Year
Anti-obesity effect of MPV-1743 A III, a novel imidazoline derivative, in genetic obesity. European journal of pharmacology, 1997, Jun-11, Volume: 328, Issue:2-3 Topics: Adipose Tissue, Brown; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Anti-Obesity Agents; Binding Sites; Cell Line; Cerebral Cortex; Eating; Female; Guanosine Diphosphate; Imidazoles; In Vitro Techniques; Indenes; Male; Mydriatics; Obesity; Protein Binding; Rats; Rats, Sprague-Dawley; Rats, Zucker; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; RNA, Messenger; Weight Gain	1997

Article

Year

Anti-obesity effect of MPV-1743 A III, a novel imidazoline derivative, in genetic obesity.

European journal of pharmacology, 1997, Jun-11, Volume: 328, Issue:2-3

Topics: Adipose Tissue, Brown; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Anti-Obesity Agents; Binding Sites; Cell Line; Cerebral Cortex; Eating; Female; Guanosine Diphosphate; Imidazoles; In Vitro Techniques; Indenes; Male; Mydriatics; Obesity; Protein Binding; Rats; Rats, Sprague-Dawley; Rats, Zucker; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; RNA, Messenger; Weight Gain

1997